LAROCHE RICHARD F JR 4
4 · NATIONAL HEALTHCARE CORP · Filed May 7, 2026
Research Summary
AI-generated summary of this filing
NHC Director Richard LaRoche Receives 7,500 Stock Options
What Happened
- Richard F. LaRoche Jr., a director of National Healthcare Corp (NHC), received a grant of 7,500 derivative securities reported as stock options on May 7, 2026. The Form 4 records the price as $0.00 (grant), so no cash purchase was made; this is an award of options rather than an open-market buy.
Key Details
- Transaction date: 2026-05-07
- Transaction type/code: Grant/Award (A) — derivative securities (stock options)
- Amount: 7,500 options; reported price on form: $0.00
- Shares owned after transaction: Not provided in the excerpt
- Footnote: Grant made under the 2020 Omnibus Equity Incentive Plan; exempt from Section 16(b) under Rule 16b-3(d) (per footnote F1)
- Filing timeliness: Reported and filed on 2026-05-07 (no late filing indicated)
Context
- These are option awards (a form of equity compensation) and do not represent an immediate market purchase or sale. Options typically vest over time and must be exercised before they convert to shares; they do not provide immediate cash unless exercised and sold. Director grants are common as compensation and should be viewed differently from open-market purchases when assessing insider sentiment.
Insider Transaction Report
Form 4
LAROCHE RICHARD F JR
Director
Transactions
- Award
Option to Purchase Common Stock [2026 Grant]
[F1]2026-05-07+7,500→ 7,500 totalExercise: $171.42From: 2027-05-07Exp: 2031-05-06→ Common Stock (7,500 underlying)
Holdings
- 213,260
Common Stock - Held in my name or my wife's name
- 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2025-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2024 Grant]
Exercise: $96.03From: 2024-05-09Exp: 2029-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2025 Grant]
Exercise: $94.66From: 2026-05-08Exp: 2030-05-07→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Signature
/s/ Richard LaRoche|2026-05-07